Sales & Marketing Is the pharma industry particularly vulnerable to inflation? The pharma industry is often thought of as one that does not struggle in difficult economic periods – even when times are hard, everyone still values their health.
News US imposes first rebates on drugs with price hikes Manufacturers will have to pay or face fines on drugs whose prices rose ahead of inflation.
News Lilly slashes insulin price 70%, patient cost cap now $35 Lilly trying to make it easier for patients to access its insulin and help Americans generally.
News Biden pledges to veto any effort to raise drug prices President Biden went after pharma on drug prices in his third State of the Union address.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.